Back

Multi-center, prospective, registry-based nationwide study of the (cost-)effectiveness of telemedicine in heart failure patients in the Netherlands - design and recruitment of the RELEASE-HF study.

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Pharmacology and other topics Remote Patient Monitoring and Telehealth HFA Premium Access Heart Failure 2022

About the speaker

Photo
Ms Jorna van Eijk

University Medical Center Utrecht, Utrecht (Netherlands (The))

30 More presentations in this session

Presentation thumbnail
Efficacy and safety of sacubitril/valsartan (LCZ696) in reducing adverse cardiovascular events and controlling hypertension among asians: a meta-analysis of randomised controlled trials
Doctor P. Vera Cruz (Quezon, PH)
Abstract Slides
Presentation thumbnail
Role of empagliflozin in diabetic patient with acute myocardial infarction who undergone percutaneous coronary intervention
Presentation thumbnail
Recovery of left ventricular ejection fraction in patients treated with sacubitril/valsartan
Doctor J. Mesquita Guimaraes (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Levosimendan bridge to therapy optimization
Doctor C. Moliner-Abos (Barcelona, ES)
Abstract Slides
Presentation thumbnail
ORal anti-coagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the ORIGAMI pilot investigation
Doctor D. D'Amario (Novara, IT)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Pharmacology and other topics

The Event

Event poster

Heart Failure 2022

21 May - 24 May 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources